Login / Signup

Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naïve Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602.

Tetsuji TerazawaTakeshi KatoMasahiro GotoKatsuya OhtaShingo NouraHironaga SatakeYoshinori KagawaHisato KawakamiHiroko HasegawaKazuhiro YanagiharaTatsushi ShingaiKen NakataMasahito KotakaMasayuki HirakiKen KonishiShiro NakaeDaisuke SakaiYukinori KurokawaToshio ShimokawaTaroh Satoh
Published in: The oncologist (2020)
Panitumumab monotherapy showed favorable efficacy and feasibility in frail or elderly patients with RAS WT unresectable CRC. Survival analysis including OS, PFS, and TTF is currently in progress.
Keyphrases